We’re thrilled to share that our Nomad Refill mini packaging solution has won Best Packaging Innovation for Perfumery at the Barcelona Perfumery Congress 2025 Awards! 🏆 This refillable, on-the-go fragrance solution is a game-changer -combining sustainability, smart design, and patented technology in one sleek package. A big thanks to our amazing teams and partners who made this possible. Let’s keep shaping the future of beauty—together. 💫 Learn more about Nomad Refill: https://ow.ly/UtNy50Wqxtf #AptarBeauty #AwardWinning #PackagingInnovation #SustainableBeauty #FragranceDesign #BarcelonaPerfumeryAwards
About us
Every day, Aptar creates “a-ha moments” for its customers and their consumers and patients by continually bringing innovations to market that convert non-dispensing packaging into breakthrough product-dispensing systems, including those that give people more effective ways to put on their favorite fragrance, kids the opportunity to pour ketchup without making a mess and patients connected technologies that help them more easily adhere to treatment. Aptar is a global leader in drug and consumer product dosing, dispensing and protection technologies. Aptar serves a number of attractive end markets including pharmaceutical, beauty, food, beverage, personal care and home care. Using market expertise, proprietary design, engineering and science to create innovative solutions for many of the world’s leading brands, Aptar in turn makes a meaningful difference in the lives, looks, health and homes of millions of patients and consumers around the world. Aptar is headquartered in Crystal Lake, Illinois and has over 13,000 dedicated employees in 20 countries. For more information, visit www.aptar.com. All of Aptar's current job openings are found at jobs.aptar.com. Job applicants should be aware of recruiting scams on the Internet and social media platforms. The scammers frequently use a company’s logo and photos or the names of its executives to give the appearance of legitimacy. The fraud targets job seekers and uses false and fraudulent offers of employment with legitimate employers, like Aptar, to steal from the victims. No applicant for employment with Aptar is ever required to pay any money as part of the job application or hiring process. In addition, Aptar’s recruiting staff sends email communications to job applicants from email addresses with the “@aptar.com” domain name only. To read more about recruiting fraud or to report an incident please see Aptar's Recruiting Fraud Statement. https://aptar.com/careers/recruiting-fraud-statement/
- Website
-
http://www.aptar.com
External link for Aptar
- Industry
- Packaging and Containers Manufacturing
- Company size
- 10,001+ employees
- Type
- Public Company
Locations
Employees at Aptar
-
Romain Marmot
President, Aptar Digital Health
-
Hedi Tlili
President, Aptar Closures at AptarGroup - Strategic Growth | Innovation | Business Transformation | Global Leadership
-
Astrid Marechal
Impact-driven | Strategy | Fast Thinker | CEO-led change | Driving Success in Automotive & Motorsports | Board Advisor | Project & Team management
-
Emmanuelle Bersier
Market Leader | Global Account Management | Strategy Consulting
Updates
-
We’re excited to announce our participation in the upcoming drinktec trade fair, on September 18-19, 2025, in Munich, Germany! Join Aptar Closures as we showcase our latest breakthrough and sustainable dispensing solutions tailored for the beverage industry. 🎟️ Interested in attending? Request your complimentary event voucher and learn more: https://ow.ly/CyTI50Wq0JQ #drinktec #AptarClosures #BeverageInnovation #BeveragePackaging #PackagingInnovations
-
-
Aptar Pharma announces its acquisition of the clinical trial materials manufacturing capabilities of Mod3 Pharma (formerly Enteris Biopharma) from SWK Holdings. This strategic move strengthens Aptar’s support for early-stage drug development by offering formulation, fill and finish services for Phase 1 and 2 clinical trials and enhances adoption of its proprietary devices in early-stage clinical programs. Gael Touya, President of Aptar Pharma, commented, “Our vision at Aptar Pharma is clear: From formulation to patient. By integrating Phase 1 and 2 clinical manufacturing capabilities, we’re not just expanding our technical footprint - we’re deepening our commitment to customers seeking a seamless and accelerated path to market. This move reinforces our position as a trusted partner from molecule to delivery, and ultimately, to the patient.” Read full press release: https://ow.ly/909O50WqeOT #AptarPharmaServices #DrugServices #FillandFinish #ClinicalTrials #GMP
-
-
We are pleased to share that Aptar has developed a dual-active material science technology engineered to simultaneously control moisture and oxygen. This technology is designed to provide a singular solution to address these degradation drivers for pharmaceutical drugs, including oral solid dose glucagon-like peptide-1 (GLP-1), medical devices and more. “This launch reflects years of development, engineering excellence, and a deep understanding of our customers’ most pressing stability challenges,” said Badre Hammond, Vice President Commercial Operations and General Manager, Aptar CSP Technologies. “There has never been a singular, standalone active material aimed at protecting against both oxidation and moisture-related degradation at this level of precision across multiple platforms. We’re proud to offer a solution that is not only scientifically differentiated but can also be commercially validated.” Learn more about this development by visiting our newsroom: https://lnkd.in/gbt6vrus
-
🌍 Today on World Allergy Day, Aptar Pharma joins the World Health Organization (WHO) and World Allergy Organization (WAO) in raising awareness about the importance of allergy prevention and treatment. According to a review by the WAO, allergic rhinitis affects over 400 million people worldwide who, to a large extent, remain underdiagnosed and undertreated. As a global market leader in allergic rhinitis, Aptar Pharma supports our customers in transforming ideas into new solutions, from formulation to patient, to give patients access to the drug delivery treatments they need. 💬 Curious how we can support your journey? Let’s connect! #WorldAllergyDay #AptarPharma #NasalDrugDelivery #AllergyAwareness
-
-
🌍 Join Aptar Pharma in support of World Skin Health Day 2025 on July 8, 2025. We are proud to stand with the global community in raising awareness for skin health. As a global leader in drug delivery, we offer a wide range of solutions for clean, convenient and sustainable skincare dispensing. From Airless+ semi-solid metered dispensing to a wide range of liquid spray pumps and Bag-on-Valve continuous dispensing, Aptar Pharma offers solutions for almost all skin medication types. Discover more about our dermal solutions and how we can support you and your projects: https://ow.ly/eonG50WlN87 #WorldSkinHealthDay #SkinHealth #AptarPharma #DermalInnovation #SustainableSolutions
-
-
We’re proud to announce that two of our Aptar Beauty experts will be speaking at the upcoming Cosmetics Innovations Conference organized by premiumbeautynews.com, themed “Smart, Ageless & Reconnected Beauty" on July 3rd in Paris, France. 💡 Marie Jacquemin, Consumer Studies Manager at Aptar Beauty, will make a presentation on “What Solutions for Inclusive Beauty Packaging?” at 16:10. 🧪 Florence Roullet, Laboratory & Quality Development Director, will take part in the roundtable “Packaging: the Challenges of Green Materials” at 16:30. Join us as we explore how innovation, inclusivity, and sustainability are shaping the future of beauty packaging. To subscribe: https://ow.ly/j7Qm50Wj1GV #AptarBeauty #CosmeticsInnovations #InclusiveBeauty #SustainablePackaging #BeautyPackaging
-
-
In case you missed it, our recent webinar on GLP-1 therapies is now available on-demand. Gain valuable insights into how our integrated solutions can accelerate your GLP-1 drug development and enhance patient engagement. Watch our short video as Audrey Chardonnet of Aptar Pharma Injectables explains more! To access the webinar, visit: https://ow.ly/JbSf50WhuEs #AptarPharma #Noble #GLP1Drugs #Injectables #DrugDevelopment #PatientExperience Noble, An Aptar Pharma Company
-
As Migraine Awareness Month comes to an end, Aptar Pharma continues to recognize the importance of supporting patients who live with this debilitating condition. As a global leader in nasal and pulmonary drug delivery solutions, our innovations deliver treatments that improve the lives of those affected by migraines. #DrugDelivery #AptarPharma #MigraineAwareness #NasalDrugDelivery #Unidose
-
-
Backed by 35 years of expertise in pMDI valve development and performance, Aptar Pharma's ZEN30 Futurity™ helps you derisk the transition and accelerate the development of your next-generation pMDI. ✔️Engineered for a smooth transition to low GWP propellants ✔️One valve, two propellants (HFA 152a and HFO 1234ze) ✔️In-house elastomer production Navigate regulatory complexity with confidence. To learn more about the ZEN30 Futurity™, visit: https://ow.ly/VGXL50WgGJP #AptarPharma #Inhalation #LowGWP #pMDI #ZEN30Futurity #LowGWP
-